Who is the lecturer invited for the JPI seminar on April 9th, 2026?

The lecturer is Mr. Yasuhiro Araki, the Director of the Clinical Trial Promotion Office, Research and Development Policy Division, Health Policy Bureau, Ministry of Health, Labour and Welfare.

When will the JPI seminar take place, and what are the hours?

The seminar is scheduled to be held on Thursday, April 09, 2026, from 09:30 to 11:30.

Can people apply for the seminar after the live session has ended?

Yes, applications for archive streaming of the seminar will be accepted even after the event has ended.

What three areas are the public and private sectors in Japan discussing to address the drug loss problem?

They are discussing (1) strengthening Japan's drug discovery capabilities, (2) rapidly delivering the latest medicines to the public, and (3) building a social system where the cycle of investment and innovation is sustained.

AI News NQ Analysis

[JPI Seminar] Ministry of Health, Labour and Welfare "Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials" to be held on Thursday, April 9th

NQ Score 50/100

AI analysis data is not yet available.

Frequently Asked Questions

Q: Who is the lecturer invited for the JPI seminar on April 9th, 2026?: A: The lecturer is Mr. Yasuhiro Araki, the Director of the Clinical Trial Promotion Office, Research and Development Policy Division, Health Policy Bureau, Ministry of Health, Labour and Welfare.
Q: What is the main title of the seminar scheduled for April 9th?: A: The title is "The Deepening 'Drug Loss' Problem and Strengthening Japan's Drug Discovery Capabilities Ministry of Health, Labour and Welfare: Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials ~ Regulatory Harmonization and Concrete Measures for the Rapid Delivery of the Latest Medicines ~".
Q: When will the JPI seminar take place, and what are the hours?: A: The seminar is scheduled to be held on Thursday, April 09, 2026, from 09:30 to 11:30.
Q: Can people apply for the seminar after the live session has ended?: A: Yes, applications for archive streaming of the seminar will be accepted even after the event has ended.
Q: What three areas are the public and private sectors in Japan discussing to address the drug loss problem?: A: They are discussing (1) strengthening Japan's drug discovery capabilities, (2) rapidly delivering the latest medicines to the public, and (3) building a social system where the cycle of investment and innovation is sustained.